Brandon O'Brien - 06 Feb 2023 Form 4 Insider Report for CORVEL CORP (CRVL)

Signature
By: Sharon O'Connor For: Brandon O'Brien
Issuer symbol
CRVL
Transactions as of
06 Feb 2023
Transactions value $
-$170,150
Form type
4
Filing time
08 Feb 2023, 15:03:39 UTC
Previous filing
06 Feb 2023
Next filing
10 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVL Common Stock Options Exercise $59,320 +1,000 +31.4% $59.32 4,182 06 Feb 2023 Direct
transaction CRVL Common Stock Sale -$183,000 -1,000 -23.9% $183.00 3,182 06 Feb 2023 Direct
transaction CRVL Common Stock Options Exercise $10,236 +117 +3.68% $87.49 3,299 06 Feb 2023 Direct
transaction CRVL Common Stock Sale -$21,411 -117 -3.55% $183.00 3,182 06 Feb 2023 Direct
transaction CRVL Common Stock Options Exercise $21,985 +313 +9.84% $70.24 3,495 06 Feb 2023 Direct
transaction CRVL Common Stock Sale -$57,279 -313 -8.96% $183.00 3,182 06 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVL Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,000 -100% $0.000000* 0 06 Feb 2023 Common Stock 1,000 $59.32 Direct F1
transaction CRVL Non-Qualified Stock Option (right to buy) Options Exercise $0 -313 -83.5% $0.000000 62 06 Feb 2023 Common Stock 313 $70.24 Direct F2
transaction CRVL Non-Qualified Stock Option (right to buy) Options Exercise $0 -117 -66.9% $0.000000 58 06 Feb 2023 Common Stock 117 $87.49 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option will vest based on achievement of certain performance criteria relating to earnings growth.
F2 Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.